The viewpoint aims to discuss the safety issues surrounding diphenhydramine and argue for its removal from OTC availability.
Analyzed reported adverse events associated with diphenhydramine.
Reviewed current use in OTC allergy medications.
Assessed implications for public health.
Identified multiple adverse events linked to diphenhydramine use.
Highlighted the need for safer alternatives in allergy treatment.
Abstract
This Viewpoint describes adverse events associated with diphenhydramine and advocates for its withdrawal from over-the-counter (OTC) allergy medications.